EBI-907

CAS No. 1581764-31-9

EBI-907( EBI907 )

Catalog No. M12260 CAS No. 1581764-31-9

EBI-907 is a highly potent, selective, orally active B-Raf V600E inhibitor with enzyme IC50 of 7 nM, A375 cell growth IC50 of 13 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1323 Get Quote
50MG 2682 Get Quote
100MG 3600 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EBI-907
  • Note
    Research use only, not for human use.
  • Brief Description
    EBI-907 is a highly potent, selective, orally active B-Raf V600E inhibitor with enzyme IC50 of 7 nM, A375 cell growth IC50 of 13 nM.
  • Description
    EBI-907 is a highly potent, selective, orally active B-Raf V600E inhibitor with enzyme IC50 of 7 nM, A375 cell growth IC50 of 13 nM; shows no anti-proliferative effects on the growth of Calu-6 cells carrying a wild-type B-Raf, exhibiting at least 40-fold (455 nM) selectivity towards B-RafV600E-dependent cells lines; demonstrates excellent in vivo efficacy in B-Raf(V600E) dependent Colo-205 tumor xenograft models in mouse.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EBI907
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    Raf
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1581764-31-9
  • Formula Weight
    506.95
  • Molecular Formula
    C23H21ClF2N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC2=C(C=C1C3=C(F)C=CC(NS(CCCF)(=O)=O)=C3Cl)C=NC4=C2C(C5CC5)=NN4
  • Chemical Name
    N-(2-chloro-3-(1-cyclopropyl-8-methoxy-3H-pyrazolo[3,4-c]isoquinolin-7-yl)-4-fluorophenyl)-3-fluoropropane-1-sulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lu B, et al. Bioorg Med Chem Lett. 2016 Feb 1;26(3):819-23.
molnova catalog
related products
  • GNE-9815

    GNE-9815 is a high kinase-selective inhibitor of RAF and targets KRAS-mutant cancers through combination therapy.

  • L-779450

    L-779450 is a potent, ATP-competitive Raf kinase inhibitor with IC50 of 10 nM.

  • GW 5074

    A potent, selective c-Raf inhibitor with IC50 of 9 nM.